D-Mannose is a natural supplement that has been shown to prevent Urinary Tract Infections (UTIs). The following research studies show the benefits of taking D-Mannose as a prophylaxis / preventative measure.
In addition to the following studies, we are gathering information and feedback directly from our customers as well as physicians and practitioners who distribute our D-Mannose to their patients. We are pleased to share that our customers are realizing great benefits from taking our D-Mannose!
Conclusions: In conclusion, in selected patients, the association of NAC, D-Mannose, and Morinda citrifolia fruit extract, allow to improve the effectiveness of antibiotic therapy maintaining the result over time in fighting the pathogenic effect and resistance of uropathogenic bacteria. It is also very important to point out how the therapeutic efficacy is associated with a reduction in urogenital discomfort that in women with long-life expectancy impacts their intimate and daily sphere.
Efficacy of N-acetylcysteine, D-mannose and Morinda citrifolia to Treat Recurrent Cystitis in Breast Cancer Survivals
Villa Erbosa Hospital
San Donato University and research Group - September 2017 (link)
Conclusions: The results of this study suggest that D-mannose can be an effective aid in acute cystitis management and also a successful prophylactic agent in a selected population.
D-mannose: a promising support for acute urinary tract infections in women. A pilot study.
European Review for Medical and Pharmacological Sciences - July 2016 (link)
Conclusions: E. coli are known to adhere to uroepithelial cells, and D-Mannose has been shown to block E. coli receptors effectively and literally flush bacteria away.
Conclusions: Mean VASp, VASu score, and average numbers of 24-hour voidings decreased significantly. D-mannose appeared to be a safe and effective treatment for recurrent UTIs in adult women. A significant difference was observed in the proportion of women remaining infection free versus antibiotic treatment.
Oral D-mannose in recurrent urinary tract infections in women: a pilot study